Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 29,437 | 13,657 | 2,559 | 196 | 8 |
| Cost of Goods | 3,250 | 1,679 | 452 | 75 | 5 |
| Gross Profit | 26,187 | 11,978 | 2,107 | 121 | 3 |
| Operating Expenses | 27,434 | 15,781 | 8,373 | 7,601 | 4,728 |
| Operating Income | -1,247 | -3,803 | -6,266 | -7,480 | -4,725 |
| Interest Expense | 7 | 0 | 2 | 13 | 5,228 |
| Other Income | 2,173 | -231 | 2,380 | -2,598 | 0 |
| Pre-tax Income | 919 | -4,034 | -3,888 | -10,091 | -9,953 |
| Income Tax | 1,181 | 214 | 1 | 0 | 0 |
| Net Income Continuous | -262 | -4,248 | -3,889 | -10,091 | -9,953 |
| Minority Interests | -1,572 | -452 | 125 | 44 | N/A |
| Net Income | $-1,834 | $-4,700 | $-3,764 | $-10,047 | $-9,953 |
| EPS Basic Total Ops | -0.65 | -1.11 | -1.04 | -3.25 | -3.90 |
| EPS Basic Continuous Ops | -0.65 | -1.11 | -1.04 | -3.25 | -3.90 |
| EPS Diluted Total Ops | -0.65 | -1.11 | -1.04 | -3.25 | -3.90 |
| EPS Diluted Continuous Ops | -0.65 | -1.11 | -1.04 | -3.25 | -3.90 |
| EBITDA(a) | $961 | $-4,001 | $-3,851 | $-10,035 | $-4,685 |